Commerzbank Reiterates “€39.00” Price Target for Evonik Industries (EVK)

Commerzbank set a €39.00 ($45.35) price target on Evonik Industries (FRA:EVK) in a research note issued to investors on Tuesday. The firm currently has a buy rating on the stock.

Other equities analysts also recently issued reports about the company. Warburg Research set a €38.00 ($44.19) target price on Evonik Industries and gave the company a buy rating in a research report on Wednesday, July 18th. Credit Suisse Group set a €34.30 ($39.88) target price on Evonik Industries and gave the company a buy rating in a research report on Wednesday, July 18th. Societe Generale set a €40.00 ($46.51) target price on Evonik Industries and gave the company a buy rating in a research report on Wednesday, July 18th. Deutsche Bank set a €40.00 ($46.51) target price on Evonik Industries and gave the company a buy rating in a research report on Wednesday, July 18th. Finally, Baader Bank set a €40.00 ($46.51) target price on Evonik Industries and gave the company a buy rating in a research report on Tuesday, July 17th. Five equities research analysts have rated the stock with a sell rating, five have given a hold rating and twelve have given a buy rating to the company’s stock. Evonik Industries currently has an average rating of Hold and a consensus price target of €34.48 ($40.09).

FRA EVK opened at €26.72 ($31.07) on Tuesday. Evonik Industries has a fifty-two week low of €26.78 ($31.14) and a fifty-two week high of €32.97 ($38.34).

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Featured Article: Hedge Funds – How They Work For Investors

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply